Taro Pharmaceutical Indus...

NYSE: TARO · Real-Time Price · USD
42.98
0.01 (0.02%)
At close: Jun 21, 2024, 9:59 PM

Taro Pharmaceutical Industries Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Revenue
629.18M 572.95M 561.35M 548.97M
Cost of Revenue
324.2M 304.63M 268.23M 252.31M
Gross Profit
304.98M 268.32M 293.12M 296.66M
Operating Income
21.51M 17.71M 184.37M 704.44M
Interest Income
56.19M 22.1M 8.19M 20.17M
Pretax Income
82.67M 38.21M 77.86M -391.07M
Net Income
53.87M 25.45M 58.27M -400.74M
Selling & General & Admin
218.94M 198.37M 113.68M 91.36M
Research & Development
64.54M 52.24M 54.54M 60.15M
Other Expenses
n/a 2.46M n/a n/a
Operating Expenses
283.47M 250.61M 168.22M 151.51M
Interest Expense
n/a 1.25M 1.65M 1.36M
Selling & Marketing Expenses
n/a 113.28M 56.62M 38.54M
Cost & Expenses
607.67M 555.24M 436.44M 403.82M
Income Tax Expense
28.8M 12.77M 19.59M 9.67M
Shares Outstanding (Basic)
37.58M 37.58M 37.64M 38.21M
Shares Outstanding (Diluted)
37.58M 37.58M 37.64M 38.21M
EPS (Basic)
1.43 0.68 1.55 -10.49
EPS (Diluted)
1.43 0.68 1.55 -10.49
EBITDA
38.4M 52.65M 164.89M -413.77M
EBIT
7.31M 20.53M 140.97M -389.71M
Depreciation & Amortization
31.09M 34.94M 25.91M 23.68M